ArticleFrontiers in immunology2022

Dupilumab improves clinical symptoms in children with Netherton syndrome by suppressing Th2-mediated inflammation.

Shi Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.